药监监测对理解布洛芬相关风险的贡献:使用FAERS数据进行描述性和不成比例分析
Cristina Anamaria Buciuman1, Carmen Maximiliana Dobrea2, Anca Butuca2
1Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Str., 020956 Bucharest, Romania.
Pharmaceuticals (Basel, Switzerland)
|February 27, 2026
概括
现实世界的数据显示,在全球范围内报告了ibuprofen不良事件. 对超过7万份报告的分析强调了潜在的风险,特别是在女性和成年人身上,强调了安全的药物管理.
科学领域:
- 药物监督 药物监督 药物监督
- 现实世界的证据分析分析.
- 药物安全 药物安全
背景情况:
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库包含有关药物安全性的大量现实数据.
- 了解易布洛芬的不良事件概况对于患者的安全至关重要.
研究的目的:
- 通过描述性和不成比例性分析,评估真实世界关于ibuprofen不良事件 (AE) 的证据.
- 为了确定潜在的药物不良影响信号进行进一步的调查.
主要方法:
- 描述性分析来自FAERS (全球收集) 的70,792份与布洛芬相关的报告.
- 使用埃文斯标准来评估信号强度的不成比例分析.
- 专注于报告的顶级不良事件和患者人口统计数据.
主要成果:
- 在70,792份报告中,ibuprofen是主要的嫌疑人.
- 女性 (47.0%) 和成年人 (31.1%) 最常受到影响.
- 口服是最常见的途径;4.3%的不良结果报告死亡.
结论:
- 现实世界的数据表明,与布洛芬使用相关的潜在风险.
- 负责任和临床指导的管理是必不可少的.
- 不成比例性分析有助于优先考虑药物-不良反应对进行进一步审查.
更多相关视频
相关概念视频
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Therapeutic Drug Monitoring: Affecting Factors
288
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
288
Analysis of Population Pharmacokinetic Data
858
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
858
Bioequivalence studies: Biowaivers
332
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
332


